SCHEMBL1432274

SCHEMBL1432274

CC(C)(C)OC(=O)NC[C@H](C(=O)NCc1ccc(N)nc1)c1ccc(F)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 1/20 0.38
▸ PDPK1 O15530 2/20 0.38
▸ MASP2 O00187 2/20 0.38
▸ HDAC1 Q13547 2/20 0.38
▸ ALOX5AP P20292 1/20 0.37
▸ FEN1 P39748 1/20 0.37
▸ NAMPT P43490 1/20 0.36
▸ GRM2 Q14416 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ FURIN P09958 1/20 0.36
▸ S1PR3 Q99500 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1902789 0.90 NAMPT (0.44) AAK1MASP2HDAC1NAMPTGRM2
SCHEMBL1901340 0.87 PDPK1 (0.39) PDPK1MASP2NAMPTFURIN
SCHEMBL1432325 0.85 PDPK1 (0.40) PDPK1MASP2NAMPTFURIN
SCHEMBL1902374 0.84 PDPK1 (0.40) PDPK1MASP2NAMPTFURIN
SCHEMBL1903653 0.84 PDPK1 (0.40) PDPK1MASP2NAMPTFURIN
SCHEMBL1901478 0.83 AAK1 (0.38) AAK1PDPK1ALOX5APFEN1S1PR3
SCHEMBL1907783 0.83 PDPK1 (0.38) PDPK1MASP2HDAC1NAMPT
SCHEMBL1431876 0.83 MASP2 (0.43) PDPK1MASP2NAMPT
SCHEMBL1902464 0.83 MASP2 (0.39) PDPK1MASP2NAMPTFURIN
SCHEMBL1899812 0.83 MASP2 (0.39) PDPK1MASP2NAMPTFURIN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011051671-A1 AMINOPYRIDINE DERIVATIVES AS KALLIKREIN INHIBITORS VANTIA LIMITED (GB) 2011-05-05 — — WO disclosed
EP-2300428-A1 AMINOPYRIDINE DERIVATIVES Vantia Limited (GB) 2011-03-30 — — EP disclosed
WO-2009133348-A1 AMINOPYRIDINE DERIVATIVES VANTIA LIMITED (GB) 2009-11-05 — — WO disclosed
Send feedback